0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Platinum based Cancer Drug Sales Market Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-20T11105
Home | Market Reports | Health| Health Conditions| Cancer
Global Platinum based Cancer Drug Sales Market Report 2022

Global Platinum based Cancer Drug Sales Market Report 2022

Code: QYRE-Auto-20T11105
Report
August 2022
131 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Market Analysis and Insights: Global Platinum based Cancer Drug Market

Due to the COVID-19 pandemic, the global Platinum based Cancer Drug market size is estimated to be worth US$ 1541.9 million in 2021 and is forecast to a readjusted size of US$ 1541.9 million by 2028 with a CAGR of 2.7% during the review period.

Fully considering the economic change by this health crisis, by Type accounting for % of the Platinum based Cancer Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Type segment is altered to an % CAGR throughout this forecast period.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
Global Platinum based Cancer Drug Scope and Market Size
The global Platinum based Cancer Drug market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Platinum based Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

Segment by Type

Cisplatin
Oxaliplatin
Carboplatin
Others

Segment by Application

Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others

BY REGION

United States
Europe
China
Japan
Southeast Asia
India
Other Regions

BY COMPANY

Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
1 Platinum based Cancer Drug Market Overview
1.1 Platinum based Cancer Drug Product Scope
1.2 Platinum based Cancer Drug Segment by Type
1.2.1 Global Platinum based Cancer Drug Sales by Type (2017 & 2021 & 2028)
1.2.2 Cisplatin
1.2.3 Oxaliplatin
1.2.4 Carboplatin
1.2.5 Others
1.3 Platinum based Cancer Drug Segment by Application
1.3.1 Global Platinum based Cancer Drug Sales Comparison by Application (2017 & 2021 & 2028)
1.3.2 Colorectal Cancer
1.3.3 Ovarian Cancer
1.3.4 Lung Cancer
1.3.5 Others
1.4 Platinum based Cancer Drug Market Estimates and Forecasts (2017-2028)
1.4.1 Global Platinum based Cancer Drug Market Size in Value Growth Rate (2017-2028)
1.4.2 Global Platinum based Cancer Drug Market Size in Volume Growth Rate (2017-2028)
1.4.3 Global Platinum based Cancer Drug Price Trends (2017-2028)
2 Platinum based Cancer Drug Estimates and Forecasts by Region
2.1 Global Platinum based Cancer Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2 Global Platinum based Cancer Drug Retrospective Market Scenario by Region (2017-2022)
2.2.1 Global Platinum based Cancer Drug Sales Market Share by Region (2017-2022)
2.2.2 Global Platinum based Cancer Drug Revenue Market Share by Region (2017-2022)
2.3 Global Platinum based Cancer Drug Market Estimates and Forecasts by Region (2023-2028)
2.3.1 Global Platinum based Cancer Drug Sales Estimates and Forecasts by Region (2023-2028)
2.3.2 Global Platinum based Cancer Drug Revenue Forecast by Region (2023-2028)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Platinum based Cancer Drug Estimates and Projections (2017-2028)
2.4.2 Europe Platinum based Cancer Drug Estimates and Projections (2017-2028)
2.4.3 China Platinum based Cancer Drug Estimates and Projections (2017-2028)
2.4.4 Japan Platinum based Cancer Drug Estimates and Projections (2017-2028)
2.4.5 Southeast Asia Platinum based Cancer Drug Estimates and Projections (2017-2028)
2.4.6 India Platinum based Cancer Drug Estimates and Projections (2017-2028)
3 Global Platinum based Cancer Drug Competition Landscape by Players
3.1 Global Top Platinum based Cancer Drug Players by Sales (2017-2022)
3.2 Global Top Platinum based Cancer Drug Players by Revenue (2017-2022)
3.3 Global Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Platinum based Cancer Drug as of 2021)
3.4 Global Platinum based Cancer Drug Average Price by Company (2017-2022)
3.5 Manufacturers Platinum based Cancer Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Platinum based Cancer Drug Market Size by Type
4.1 Global Platinum based Cancer Drug Historic Market Review by Type (2017-2022)
4.1.1 Global Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
4.1.2 Global Platinum based Cancer Drug Revenue Market Share by Type (2017-2022)
4.1.3 Global Platinum based Cancer Drug Price by Type (2017-2022)
4.2 Global Platinum based Cancer Drug Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Platinum based Cancer Drug Sales Forecast by Type (2023-2028)
4.2.2 Global Platinum based Cancer Drug Revenue Forecast by Type (2023-2028)
4.2.3 Global Platinum based Cancer Drug Price Forecast by Type (2023-2028)
5 Global Platinum based Cancer Drug Market Size by Application
5.1 Global Platinum based Cancer Drug Historic Market Review by Application (2017-2022)
5.1.1 Global Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
5.1.2 Global Platinum based Cancer Drug Revenue Market Share by Application (2017-2022)
5.1.3 Global Platinum based Cancer Drug Price by Application (2017-2022)
5.2 Global Platinum based Cancer Drug Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Platinum based Cancer Drug Sales Forecast by Application (2023-2028)
5.2.2 Global Platinum based Cancer Drug Revenue Forecast by Application (2023-2028)
5.2.3 Global Platinum based Cancer Drug Price Forecast by Application (2023-2028)
6 United States Platinum based Cancer Drug Market Facts & Figures
6.1 United States Platinum based Cancer Drug Sales by Company
6.1.1 United States Platinum based Cancer Drug Sales by Company (2017-2022)
6.1.2 United States Platinum based Cancer Drug Revenue by Company (2017-2022)
6.2 United States Platinum based Cancer Drug Sales Breakdown by Type
6.2.1 United States Platinum based Cancer Drug Sales Breakdown by Type (2017-2022)
6.2.2 United States Platinum based Cancer Drug Sales Breakdown by Type (2023-2028)
6.3 United States Platinum based Cancer Drug Sales Breakdown by Application
6.3.1 United States Platinum based Cancer Drug Sales Breakdown by Application (2017-2022)
6.3.2 United States Platinum based Cancer Drug Sales Breakdown by Application (2023-2028)
7 Europe Platinum based Cancer Drug Market Facts & Figures
7.1 Europe Platinum based Cancer Drug Sales by Company
7.1.1 Europe Platinum based Cancer Drug Sales by Company (2017-2022)
7.1.2 Europe Platinum based Cancer Drug Revenue by Company (2017-2022)
7.2 Europe Platinum based Cancer Drug Sales Breakdown by Type
7.2.1 Europe Platinum based Cancer Drug Sales Breakdown by Type (2017-2022)
7.2.2 Europe Platinum based Cancer Drug Sales Breakdown by Type (2023-2028)
7.3 Europe Platinum based Cancer Drug Sales Breakdown by Application
7.3.1 Europe Platinum based Cancer Drug Sales Breakdown by Application (2017-2022)
7.3.2 Europe Platinum based Cancer Drug Sales Breakdown by Application (2023-2028)
8 China Platinum based Cancer Drug Market Facts & Figures
8.1 China Platinum based Cancer Drug Sales by Company
8.1.1 China Platinum based Cancer Drug Sales by Company (2017-2022)
8.1.2 China Platinum based Cancer Drug Revenue by Company (2017-2022)
8.2 China Platinum based Cancer Drug Sales Breakdown by Type
8.2.1 China Platinum based Cancer Drug Sales Breakdown by Type (2017-2022)
8.2.2 China Platinum based Cancer Drug Sales Breakdown by Type (2023-2028)
8.3 China Platinum based Cancer Drug Sales Breakdown by Application
8.3.1 China Platinum based Cancer Drug Sales Breakdown by Application (2017-2022)
8.3.2 China Platinum based Cancer Drug Sales Breakdown by Application (2023-2028)
9 Japan Platinum based Cancer Drug Market Facts & Figures
9.1 Japan Platinum based Cancer Drug Sales by Company
9.1.1 Japan Platinum based Cancer Drug Sales by Company (2017-2022)
9.1.2 Japan Platinum based Cancer Drug Revenue by Company (2017-2022)
9.2 Japan Platinum based Cancer Drug Sales Breakdown by Type
9.2.1 Japan Platinum based Cancer Drug Sales Breakdown by Type (2017-2022)
9.2.2 Japan Platinum based Cancer Drug Sales Breakdown by Type (2023-2028)
9.3 Japan Platinum based Cancer Drug Sales Breakdown by Application
9.3.1 Japan Platinum based Cancer Drug Sales Breakdown by Application (2017-2022)
9.3.2 Japan Platinum based Cancer Drug Sales Breakdown by Application (2023-2028)
10 Southeast Asia Platinum based Cancer Drug Market Facts & Figures
10.1 Southeast Asia Platinum based Cancer Drug Sales by Company
10.1.1 Southeast Asia Platinum based Cancer Drug Sales by Company (2017-2022)
10.1.2 Southeast Asia Platinum based Cancer Drug Revenue by Company (2017-2022)
10.2 Southeast Asia Platinum based Cancer Drug Sales Breakdown by Type
10.2.1 Southeast Asia Platinum based Cancer Drug Sales Breakdown by Type (2017-2022)
10.2.2 Southeast Asia Platinum based Cancer Drug Sales Breakdown by Type (2023-2028)
10.3 Southeast Asia Platinum based Cancer Drug Sales Breakdown by Application
10.3.1 Southeast Asia Platinum based Cancer Drug Sales Breakdown by Application (2017-2022)
10.3.2 Southeast Asia Platinum based Cancer Drug Sales Breakdown by Application (2023-2028)
11 India Platinum based Cancer Drug Market Facts & Figures
11.1 India Platinum based Cancer Drug Sales by Company
11.1.1 India Platinum based Cancer Drug Sales by Company (2017-2022)
11.1.2 India Platinum based Cancer Drug Revenue by Company (2017-2022)
11.2 India Platinum based Cancer Drug Sales Breakdown by Type
11.2.1 India Platinum based Cancer Drug Sales Breakdown by Type (2017-2022)
11.2.2 India Platinum based Cancer Drug Sales Breakdown by Type (2023-2028)
11.3 India Platinum based Cancer Drug Sales Breakdown by Application
11.3.1 India Platinum based Cancer Drug Sales Breakdown by Application (2017-2022)
11.3.2 India Platinum based Cancer Drug Sales Breakdown by Application (2023-2028)
12 Company Profiles and Key Figures in Platinum based Cancer Drug Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.1.4 Sanofi Platinum based Cancer Drug Products Offered
12.1.5 Sanofi Recent Development
12.2 Hengrui Medicine
12.2.1 Hengrui Medicine Corporation Information
12.2.2 Hengrui Medicine Business Overview
12.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.2.4 Hengrui Medicine Platinum based Cancer Drug Products Offered
12.2.5 Hengrui Medicine Recent Development
12.3 ASK Pharma
12.3.1 ASK Pharma Corporation Information
12.3.2 ASK Pharma Business Overview
12.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.3.4 ASK Pharma Platinum based Cancer Drug Products Offered
12.3.5 ASK Pharma Recent Development
12.4 Yi Bai Pharmaceutical
12.4.1 Yi Bai Pharmaceutical Corporation Information
12.4.2 Yi Bai Pharmaceutical Business Overview
12.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Products Offered
12.4.5 Yi Bai Pharmaceutical Recent Development
12.5 Qilu Pharmaceutical
12.5.1 Qilu Pharmaceutical Corporation Information
12.5.2 Qilu Pharmaceutical Business Overview
12.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Products Offered
12.5.5 Qilu Pharmaceutical Recent Development
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Business Overview
12.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.6.4 Teva Platinum based Cancer Drug Products Offered
12.6.5 Teva Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.7.4 Pfizer Platinum based Cancer Drug Products Offered
12.7.5 Pfizer Recent Development
12.8 Dr Reddy's Laboratories
12.8.1 Dr Reddy's Laboratories Corporation Information
12.8.2 Dr Reddy's Laboratories Business Overview
12.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Products Offered
12.8.5 Dr Reddy's Laboratories Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Business Overview
12.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.9.4 Mylan Platinum based Cancer Drug Products Offered
12.9.5 Mylan Recent Development
12.10 Sun Pharma
12.10.1 Sun Pharma Corporation Information
12.10.2 Sun Pharma Business Overview
12.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.10.4 Sun Pharma Platinum based Cancer Drug Products Offered
12.10.5 Sun Pharma Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Business Overview
12.11.3 Novartis Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.11.4 Novartis Platinum based Cancer Drug Products Offered
12.11.5 Novartis Recent Development
12.12 Debiopharm
12.12.1 Debiopharm Corporation Information
12.12.2 Debiopharm Business Overview
12.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.12.4 Debiopharm Platinum based Cancer Drug Products Offered
12.12.5 Debiopharm Recent Development
12.13 Accord Healthcare
12.13.1 Accord Healthcare Corporation Information
12.13.2 Accord Healthcare Business Overview
12.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.13.4 Accord Healthcare Platinum based Cancer Drug Products Offered
12.13.5 Accord Healthcare Recent Development
12.14 SK Chemicals
12.14.1 SK Chemicals Corporation Information
12.14.2 SK Chemicals Business Overview
12.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2017-2022)
12.14.4 SK Chemicals Platinum based Cancer Drug Products Offered
12.14.5 SK Chemicals Recent Development
13 Platinum based Cancer Drug Manufacturing Cost Analysis
13.1 Platinum based Cancer Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Platinum based Cancer Drug
13.4 Platinum based Cancer Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Platinum based Cancer Drug Distributors List
14.3 Platinum based Cancer Drug Customers
15 Market Dynamics
15.1 Platinum based Cancer Drug Industry Trends
15.2 Platinum based Cancer Drug Market Drivers
15.3 Platinum based Cancer Drug Market Challenges
15.4 Platinum based Cancer Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
    Table 1. Global Platinum based Cancer Drug Sales (US$ Million) Growth Rate by Type (2017 & 2021 & 2028)
    Table 2. Global Platinum based Cancer Drug Sales ((US$ Million)) Comparison by Application (2017 & 2021 & 2028)
    Table 3. Global Platinum based Cancer Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 4. Global Platinum based Cancer Drug Sales (K Units) by Region (2017-2022)
    Table 5. Global Platinum based Cancer Drug Sales Market Share by Region (2017-2022)
    Table 6. Global Platinum based Cancer Drug Revenue (US$ Million) Market Share by Region (2017-2022))
    Table 7. Global Platinum based Cancer Drug Revenue Share by Region (2017-2022)
    Table 8. Global Platinum based Cancer Drug Sales (K Units) Forecast by Region (2023-2028)
    Table 9. Global Platinum based Cancer Drug Sales Market Share Forecast by Region (2023-2028)
    Table 10. Global Platinum based Cancer Drug Revenue (US$ Million) Forecast by Region (2023-2028)
    Table 11. Global Platinum based Cancer Drug Revenue Share Forecast by Region (2023-2028)
    Table 12. Global Platinum based Cancer Drug Sales by Company (K Units) & (2017-2022)
    Table 13. Global Platinum based Cancer Drug Sales Share by Company (2017-2022)
    Table 14. Global Platinum based Cancer Drug Revenue by Company (US$ Million) & (2017-2022)
    Table 15. Global Platinum based Cancer Drug Revenue Share by Company (2017-2022)
    Table 16. Global Platinum based Cancer Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum based Cancer Drug as of 2021)
    Table 17. Global Market Platinum based Cancer Drug Average Price by Company (USD/Unit) & (2017-2022)
    Table 18. Manufacturers Platinum based Cancer Drug Manufacturing Sites and Area Served
    Table 19. Manufacturers Platinum based Cancer Drug Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 22. Global Platinum based Cancer Drug Sales Share by Type (2017-2022)
    Table 23. Global Platinum based Cancer Drug Revenue Market Share by Type (2017-2022) & (US$ Million)
    Table 24. Global Platinum based Cancer Drug Price by Type (2017-2022) & (USD/Unit)
    Table 25. Global Platinum based Cancer Drug Sales Share by Type (2023-2028)
    Table 26. Global Platinum based Cancer Drug Revenue Market Share by Type (2023-2028) & (US$ Million)
    Table 27. Global Platinum based Cancer Drug Revenue Share by Type (2023-2028)
    Table 28. Global Platinum based Cancer Drug Price by Type (2023-2028) & (USD/Unit)
    Table 29. Global Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 30. Global Platinum based Cancer Drug Sales Share by Application (2017-2022)
    Table 31. Global Platinum based Cancer Drug Revenue Market Share by Application (2017-2022) & (US$ Million)
    Table 32. Global Platinum based Cancer Drug Price by Application (2017-2022) & (USD/Unit)
    Table 33. Global Platinum based Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 34. Global Platinum based Cancer Drug Sales Share by Application (2023-2028)
    Table 35. Global Platinum based Cancer Drug Revenue Market Share by Application (2023-2028) & (US$ Million)
    Table 36. Global Platinum based Cancer Drug Revenue Share by Application (2023-2028)
    Table 37. Global Platinum based Cancer Drug Price by Application (2023-2028) & (USD/Unit)
    Table 38. United States Platinum based Cancer Drug Sales by Company (2017-2022) & (K Units)
    Table 39. United States Platinum based Cancer Drug Sales Market Share by Company (2017-2022)
    Table 40. United States Platinum based Cancer Drug Revenue by Company (2017-2022) & (US$ Million)
    Table 41. United States Platinum based Cancer Drug Revenue Market Share by Company (2017-2022)
    Table 42. United States Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 43. United States Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Table 44. United States Platinum based Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 45. United States Platinum based Cancer Drug Sales Market Share by Type (2023-2028)
    Table 46. United States Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 47. United States Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Table 48. United States Platinum based Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 49. United States Platinum based Cancer Drug Sales Market Share by Application (2023-2028)
    Table 50. Europe Platinum based Cancer Drug Sales by Company (2017-2022) & (K Units)
    Table 51. Europe Platinum based Cancer Drug Sales Market Share by Company (2017-2022)
    Table 52. Europe Platinum based Cancer Drug Revenue by Company (2017-2022) & (US$ Million)
    Table 53. Europe Platinum based Cancer Drug Revenue Market Share by Company (2017-2022)
    Table 54. Europe Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 55. Europe Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Table 56. Europe Platinum based Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 57. Europe Platinum based Cancer Drug Sales Market Share by Type (2023-2028)
    Table 58. Europe Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 59. Europe Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Table 60. Europe Platinum based Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 61. Europe Platinum based Cancer Drug Sales Market Share by Application (2023-2028)
    Table 62. China Platinum based Cancer Drug Sales by Company (2017-2022) & (K Units)
    Table 63. China Platinum based Cancer Drug Sales Market Share by Company (2017-2022)
    Table 64. China Platinum based Cancer Drug Revenue by Company (2017-2022) & (US$ Million)
    Table 65. China Platinum based Cancer Drug Revenue Market Share by Company (2017-2022)
    Table 66. China Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 67. China Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Table 68. China Platinum based Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 69. China Platinum based Cancer Drug Sales Market Share by Type (2023-2028)
    Table 70. China Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 71. China Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Table 72. China Platinum based Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 73. China Platinum based Cancer Drug Sales Market Share by Application (2023-2028)
    Table 74. Japan Platinum based Cancer Drug Sales by Company (2017-2022) & (K Units)
    Table 75. Japan Platinum based Cancer Drug Sales Market Share by Company (2017-2022)
    Table 76. Japan Platinum based Cancer Drug Revenue by Company (2017-2022) & (US$ Million)
    Table 77. Japan Platinum based Cancer Drug Revenue Market Share by Company (2017-2022)
    Table 78. Japan Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 79. Japan Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Table 80. Japan Platinum based Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 81. Japan Platinum based Cancer Drug Sales Market Share by Type (2023-2028)
    Table 82. Japan Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 83. Japan Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Table 84. Japan Platinum based Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 85. Japan Platinum based Cancer Drug Sales Market Share by Application (2023-2028)
    Table 86. Southeast Asia Platinum based Cancer Drug Sales by Company (2017-2022) & (K Units)
    Table 87. Southeast Asia Platinum based Cancer Drug Sales Market Share by Company (2017-2022)
    Table 88. Southeast Asia Platinum based Cancer Drug Revenue by Company (2017-2022) & (US$ Million)
    Table 89. Southeast Asia Platinum based Cancer Drug Revenue Market Share by Company (2017-2022)
    Table 90. Southeast Asia Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 91. Southeast Asia Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Table 92. Southeast Asia Platinum based Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 93. Southeast Asia Platinum based Cancer Drug Sales Market Share by Type (2023-2028)
    Table 94. Southeast Asia Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 95. Southeast Asia Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Table 96. Southeast Asia Platinum based Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 97. Southeast Asia Platinum based Cancer Drug Sales Market Share by Application (2023-2028)
    Table 98. India Platinum based Cancer Drug Sales by Company (2017-2022) & (K Units)
    Table 99. India Platinum based Cancer Drug Sales Market Share by Company (2017-2022)
    Table 100. India Platinum based Cancer Drug Revenue by Company (2017-2022) & (US$ Million)
    Table 101. India Platinum based Cancer Drug Revenue Market Share by Company (2017-2022)
    Table 102. India Platinum based Cancer Drug Sales by Type (2017-2022) & (K Units)
    Table 103. India Platinum based Cancer Drug Sales Market Share by Type (2017-2022)
    Table 104. India Platinum based Cancer Drug Sales by Type (2023-2028) & (K Units)
    Table 105. India Platinum based Cancer Drug Sales Market Share by Type (2023-2028)
    Table 106. India Platinum based Cancer Drug Sales by Application (2017-2022) & (K Units)
    Table 107. India Platinum based Cancer Drug Sales Market Share by Application (2017-2022)
    Table 108. India Platinum based Cancer Drug Sales by Application (2023-2028) & (K Units)
    Table 109. India Platinum based Cancer Drug Sales Market Share by Application (2023-2028)
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Business Overview
    Table 112. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Sanofi Platinum based Cancer Drug Product
    Table 114. Sanofi Recent Development
    Table 115. Hengrui Medicine Corporation Information
    Table 116. Hengrui Medicine Description and Business Overview
    Table 117. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Hengrui Medicine Platinum based Cancer Drug Product
    Table 119. Hengrui Medicine Recent Development
    Table 120. ASK Pharma Corporation Information
    Table 121. ASK Pharma Description and Business Overview
    Table 122. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. ASK Pharma Platinum based Cancer Drug Product
    Table 124. ASK Pharma Recent Development
    Table 125. Yi Bai Pharmaceutical Corporation Information
    Table 126. Yi Bai Pharmaceutical Description and Business Overview
    Table 127. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Yi Bai Pharmaceutical Platinum based Cancer Drug Product
    Table 129. Yi Bai Pharmaceutical Recent Development
    Table 130. Qilu Pharmaceutical Corporation Information
    Table 131. Qilu Pharmaceutical Description and Business Overview
    Table 132. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Qilu Pharmaceutical Platinum based Cancer Drug Product
    Table 134. Qilu Pharmaceutical Recent Development
    Table 135. Teva Corporation Information
    Table 136. Teva Description and Business Overview
    Table 137. Teva Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Teva Platinum based Cancer Drug Product
    Table 139. Teva Recent Development
    Table 140. Pfizer Corporation Information
    Table 141. Pfizer Description and Business Overview
    Table 142. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Pfizer Platinum based Cancer Drug Product
    Table 144. Pfizer Recent Development
    Table 145. Dr Reddy's Laboratories Corporation Information
    Table 146. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Dr Reddy's Laboratories Description and Business Overview
    Table 148. Dr Reddy's Laboratories Platinum based Cancer Drug Product
    Table 149. Dr Reddy's Laboratories Recent Development
    Table 150. Mylan Corporation Information
    Table 151. Mylan Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. Mylan Description and Business Overview
    Table 153. Mylan Platinum based Cancer Drug Product
    Table 154. Mylan Recent Development
    Table 155. Sun Pharma Corporation Information
    Table 156. Sun Pharma Description and Business Overview
    Table 157. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Sun Pharma Platinum based Cancer Drug Product
    Table 159. Sun Pharma Recent Development
    Table 160. Novartis Corporation Information
    Table 161. Novartis Description and Business Overview
    Table 162. Novartis Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 163. Novartis Platinum based Cancer Drug Product
    Table 164. Novartis Recent Development
    Table 165. Debiopharm Corporation Information
    Table 166. Debiopharm Description and Business Overview
    Table 167. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 168. Debiopharm Platinum based Cancer Drug Product
    Table 169. Debiopharm Recent Development
    Table 170. Accord Healthcare Corporation Information
    Table 171. Accord Healthcare Description and Business Overview
    Table 172. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 173. Accord Healthcare Platinum based Cancer Drug Product
    Table 174. Accord Healthcare Recent Development
    Table 175. SK Chemicals Corporation Information
    Table 176. SK Chemicals Description and Business Overview
    Table 177. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 178. SK Chemicals Platinum based Cancer Drug Product
    Table 179. SK Chemicals Recent Development
    Table 180. Production Base and Market Concentration Rate of Raw Material
    Table 181. Key Suppliers of Raw Materials
    Table 182. Platinum based Cancer Drug Distributors List
    Table 183. Platinum based Cancer Drug Customers List
    Table 184. Platinum based Cancer Drug Market Trends
    Table 185. Platinum based Cancer Drug Market Drivers
    Table 186. Platinum based Cancer Drug Market Challenges
    Table 187. Platinum based Cancer Drug Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Platinum based Cancer Drug Product Picture
    Figure 2. Global Platinum based Cancer Drug Sales Market Share by Type in 2021 & 2028
    Figure 3. Cisplatin Product Picture
    Figure 4. Oxaliplatin Product Picture
    Figure 5. Carboplatin Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Platinum based Cancer Drug Sales Market Share by Application in 2021 & 2028
    Figure 8. Colorectal Cancer Examples
    Figure 9. Ovarian Cancer Examples
    Figure 10. Lung Cancer Examples
    Figure 11. Others Examples
    Figure 12. Global Platinum based Cancer Drug Sales, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Platinum based Cancer Drug Sales Growth Rate (2017-2028) & (US$ Million)
    Figure 14. Global Platinum based Cancer Drug Sales (K Units) Growth Rate (2017-2028)
    Figure 15. Global Platinum based Cancer Drug Price Trends Growth Rate (2017-2028) & (USD/Unit)
    Figure 16. Global Platinum based Cancer Drug Revenue Market Share by Region: 2021 VS 2028
    Figure 17. United States Platinum based Cancer Drug Revenue (US$ Million) Growth Rate (2017-2028)
    Figure 18. United States Platinum based Cancer Drug Sales (K Units) Growth Rate (2017-2028)
    Figure 19. Europe Platinum based Cancer Drug Revenue (US$ Million) Growth Rate (2017-2028)
    Figure 20. Europe Platinum based Cancer Drug Sales (US$ Million) Growth Rate (2017-2028)
    Figure 21. China Platinum based Cancer Drug Revenue (US$ Million) Growth Rate (2017-2028)
    Figure 22. China Platinum based Cancer Drug Sales (US$ Million) and Growth Rate (2017-2028)
    Figure 23. Japan Platinum based Cancer Drug Revenue (US$ Million) Growth Rate (2017-2028)
    Figure 24. Japan Platinum based Cancer Drug Sales (US$ Million) Growth Rate (2017-2028)
    Figure 25. Southeast Asia Platinum based Cancer Drug Revenue (US$ Million) Growth Rate (2017-2028)
    Figure 26. Southeast Asia Platinum based Cancer Drug Sales (US$ Million) Growth Rate (2017-2028)
    Figure 27. India Platinum based Cancer Drug Revenue (US$ Million) Growth Rate (2017-2028)
    Figure 28. India Platinum based Cancer Drug Sales (US$ Million) Growth Rate (2017-2028)
    Figure 29. Global 5 Largest Platinum based Cancer Drug Players Market Share by Revenue in Platinum based Cancer Drug: 2017 & 2021
    Figure 30. Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 31. Global Platinum based Cancer Drug Revenue Share by Type (2017-2022)
    Figure 32. Global Platinum based Cancer Drug Revenue Share by Application (2017-2022)
    Figure 33. Global Platinum based Cancer Drug Revenue Growth Rate by Application in 2017 & 2021
    Figure 34. United States Platinum based Cancer Drug Sales Market Share by Type in 2021
    Figure 35. United States Platinum based Cancer Drug Sales Market Share by Application in 2021
    Figure 36. Europe Platinum based Cancer Drug Sales Market Share by Type in 2021
    Figure 37. Europe Platinum based Cancer Drug Sales Market Share by Application in 2021
    Figure 38. China Platinum based Cancer Drug Sales Market Share by Type in 2021
    Figure 39. China Platinum based Cancer Drug Sales Market Share by Application in 2021
    Figure 40. Japan Platinum based Cancer Drug Sales Market Share by Type in 2021
    Figure 41. Japan Platinum based Cancer Drug Sales Market Share by Application in 2021
    Figure 42. Southeast Asia Platinum based Cancer Drug Sales Market Share by Type in 2021
    Figure 43. Southeast Asia Platinum based Cancer Drug Sales Market Share by Application in 2021
    Figure 44. India Platinum based Cancer Drug Sales Market Share by Type in 2021
    Figure 45. India Platinum based Cancer Drug Sales Market Share by Application in 2021
    Figure 46. Key Raw Materials Price Trend
    Figure 47. Manufacturing Cost Structure of Platinum based Cancer Drug
    Figure 48. Manufacturing Process Analysis of Platinum based Cancer Drug
    Figure 49. Platinum based Cancer Drug Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4000
This license allows only one user to access the PDF.

Electronic (PDF)
$6000
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8000
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Global Radiotherapy Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Radiotherapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-9H875
Thu Sep 22 00:00:00 UTC 2022

Add to Cart

Global Platinum based Cancer Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
Global Platinum based Cancer Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-1U12322
Tue Sep 20 00:00:00 UTC 2022

Add to Cart

Global Enzymatic Debridement Market Insights Forecast to 2026
Global Enzymatic Debridement Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-11F2665
Thu Sep 15 00:00:00 UTC 2022

Add to Cart